STOCKS TELEGRAPH

Tag: ADTX stock

  • Aditxt (ADTX) Stock Rises Sharply In Pre-Market As Investors React To New Strategy

    Aditxt (ADTX) Stock Rises Sharply In Pre-Market As Investors React To New Strategy

    Aditxt, Inc. (NASDAQ: ADTX) saw a sharp rise in its stock value after announcing key strategic initiatives. As of the latest pre-market check, ADTX shares were trading at $6.12, up 40.05%, reflecting strong investor confidence.

    Advancements in Clinical Trials and Regulatory Efforts

    Aditxt provided a corporate update highlighting progress across its subsidiaries. Adimune Inc. is advancing toward clinical trials, having shipped drug substances for ADI-100. It is preparing an Investigational New Drug (IND) application for Stiff Person Syndrome (SPS) in partnership with the Mayo Clinic and a Clinical Trial Application for Type 1 Diabetes (T1D) and Psoriasis in Germany. Clinical trials for these conditions are planned in both Germany and the U.S.

    Pearsanta Prepares for IPO and Commercial Launch

    Pearsanta, Inc., Aditxt’s precision diagnostics subsidiary, is set for a commercial launch in late 2025, starting with blood-based tests for Prostate Cancer and Endometriosis. The company has engaged Dominari Securities LLC as the lead underwriter for its planned IPO, aiming to fund commercialization and expand its Mitomic Technology platform for early cancer detection. A randomized controlled study for the Mitomic Prostate Test is also in progress.

    Adivue Focuses on Neurological Monitoring

    Following its acquisition of Brain Scientific assets, Aditxt is launching commercialization efforts through its subsidiary, Adivue, Inc. Adivue is working toward FDA re-approval of Brain Scientific’s electroencephalogram (EEG) device and establishing strategic partnerships for product development and commercial launch.

    Strategic Partnerships and Business Expansion

    Aditxt has extended its agreement with Appili Therapeutics, Inc. through March 2025, completing the required $250,000 payments. The company is also evaluating additional opportunities with Appili. Similarly, ADTXand Evofem Biosciences, Inc. continue discussions on integrating Evofem into Aditxt’s business acceleration platform.

    Commitment to Transparency with Weekly Updates

    To enhance communication, the company is launching the Aditxt Weekly Update series on March 21, 2025. The first session will feature a discussion between CEO Amro Albanna and Saundra Pelletier, offering insights into corporate strategy and future plans.

    ADTX remains focused on advancing subsidiaries toward key milestones while executing its acquisition strategy, reinforcing its commitment to innovation and growth.

  • Decoding The Spike: Understanding Aditxt (ADTX) Shares’ Significant Increase

    Decoding The Spike: Understanding Aditxt (ADTX) Shares’ Significant Increase

    Aditxt, Inc. (NASDAQ: ADTX) is observing a notable surge of 25.47% in its shares during the current session, escalating to a price of $3.99. This significant increase in ADTX shares within the US market can be directly attributed to the disclosure of an acquisition agreement.

    Aditxt (ADTX) officially stated today that it has reached a formal arrangement agreement to acquire Appili Therapeutics Inc. is a biopharmaceutical company that emphasis on developing drugs for infectious illnesses and medical countermeasures.

    Adivir, Inc., Aditxt’s wholly owned subsidiary, has agreed to purchase all of Appili’s issued and outstanding Class A common shares under a court-approved plan of arrangement under the Canada Business Corporations Act.

    The FDA-approved LIKMEZ (formerly ATI-1501), the ATI-1701 biodefense program supported by a USD $14 million non-dilutive award from the US Department of Defense, and ATI-1801, a topical formulation aimed at cutaneous leishmaniasis—a crippling disease that causes pain and disfigurement—are just a few of the varied portfolio items that Appili has developed since its establishment in 2015.

    This acquisition will enrich Aditxt’s array of subsidiaries and foster synergies with its existing initiatives, notably in precision diagnostics. The amalgamation of Appili’s proficiency and product lines will facilitate a holistic approach to public health, encompassing early detection, prevention, and treatment. Collaborative opportunities within the Aditxt ecosystem promise to streamline patient care, from early detection through precise diagnostics to tailored treatment strategies.

    The incorporation of Appili into Aditxt’s framework signifies another stride in advancing promising health innovations. With the integration of Appili’s proven track record and broad portfolio in biodefense and infectious illnesses, Aditxt is well-positioned to have a substantial impact on the development of public health solutions.

    Under the Canada Business Corporations Act, the Transaction will take place through a plan of arrangement that has been approved by the court. Adivir will purchase all issued and outstanding Appili Shares in accordance with the provisions of the Arrangement Agreement, and each Appili Shareholder will receive US$0.0467 for each Appili Share held in addition to 0.002745004 of a share of Aditxt’s common stock.

    The Transaction is contingent upon the approval of at least two-thirds of the votes cast at the special meeting of the Appili Shareholders, projected to convene before the conclusion of calendar Q2 2024 for approval of the Transaction.

  • On What Basis Did ADTX Stock Rise In Premarket Trading?

    As of Tuesday’s last check, Aditxt Inc. (ADTX) was up 20.43% at $2.83 in pre-market trading hours. ADTX closed the last trading session unchanged at $2.35. Shares of ADTX traded between $2.27 and $2.55. ADTX traded 0.71 million shares, which was higher than its daily average of 0.27 million shares over 100 days. ADTX stock gained 2.17% in the last five days, while they lost -10.31% last month. Recent developments may provide more insight into ADTX stock as it has risen without current news.

    ADTX has anything new happened recently?

    Aditxt develops technologies specifically focused on the improvement of immune health through immune monitoring and reprogramming. In the ADTX immune monitoring technology, a comprehensive immune profile is provided to each patient on a personal basis. ADTX’s immune reprogramming technology is currently at the preclinical stage and targets transplant rejection, autoimmune diseases, and allergies by retraining the immune system to induce tolerance.

    Aditxt announced a new and improved version of its AditxtScore for COVID-19.

    • AditxtScore for COVID-19 is a multidimensional immune response test that monitors several combinations of the immune system’s reactions to certain antigens at the same time.
    • ADTX also enhanced its AditxtScore for COVID-19 to include a SARS-CoV-2 virus neutralizing antibody test, allowing it to assess an individual’s immune response.
    • AditxtScore for COVID-19 was released in August of 2020.
    • By comparing multiple antigens associated with the SARS-CoV-2 virus, it provides a detailed picture of an individual’s immune response.
    • The multi-multiplex screening tool developed by ADTX gives an individual a comprehensive picture of their immune response based on an expanded set of biomarkers associated with SARS-CoV-2.
    • AditxtScore for COVID-19 now includes the ability to measure neutralizing antibodies, which are virus-specific antibodies that prevent infection by preventing viral particles from entering cells.
    • As a result of AditxtScore’s precision and ability to measure individual’s reaction to COVID-19, clinicians can better understand a patient’s immune response to COVID-19, whether incurred through exposure, infection or vaccination.
    • This tool can also identify individuals who are susceptible to SARS-CoV-2 infection for a variety of reasons, such as their inability to respond adequately to vaccination or infection, as well as their lack of prior exposure to the virus.

    How ADTX Stock will be leveraging AditxtScore?

    Based on ADTX’s research on individual immune responses to COVID-19 and COVID-19 vaccinations, ADTX found that the intensity, duration, and timing of antibody responses can vary widely. AditxtScore with neutralizing antibody diagnostics for COVID-19 enables ADTX to provide more detailed information about how well a person’s immune system responds to the virus as more people become vaccinated or exposed to the virus.

  • What changed for these 50 stocks in Pre-Market Session?

    What changed for these 50 stocks in Pre-Market Session?

    Naked Brand Group Limited (NAKD) stock plunged -10.0% to $0.26 in the pre-market trading.

    Arcimoto Inc. (NASDAQ: FUV) shares are trading down -8.25% at $14.68 at the time of writing after Arcimoto and the city of Orlando launched a joint municipal pilot program to test ultra-efficient Electric Vehicles in city fleets. The company’s 52-week range was noted as $0.97 to $10.49. Analysts have a consensus price target of $8.

    HighPoint Resources Corporation (HPR) tumbled over -5.56% at $10.7 in pre-market trading today after Laredo Petroleum announced the appointment of Jarvis Hollingsworth and Lori Lancaster to the board of directors.

    Phoenix New Media Limited (FENG), an Internet Content & Information company, dropped about -4.29% at $2.23 in pre-market trading Friday after the company announced a special cash dividend of US$1.3712 per ADS.

    Ayro Inc. (AYRO) stock moved up 7.12 percent to $6.62 in the pre-market trading as the company revealed Q3 results.

    Titan Pharmaceuticals Inc. (TTNP) gained over 59.94% at $0.2735 in pre-market trading Friday 20 November 2020 following the announcement of its quarterly results.

    VAALCO Energy Inc. (EGY) is down more than -6.21% at $1.66 in pre-market hours Friday 20 November 2020 as the company announced that it has signed a sale and purchase agreement to acquire Sasol Gabon S.A.’s 27.8% working interest in the Etame Marin block offshore Gabon. The stock had jumped over 31.11% to $1.77 in the last trading session.

    Before the trading started on 20 November 2020, CIIG Merger Corp. (CIIC) is down -3.18% to reach $16.46. It has been trading in a 52-week range of $9.30 to $13.70.

    Kandi Technologies Group Inc. (KNDI) stock plunged -1.53% to $14.19 in the pre-market trading as the news surfaced that the company’s EV is entitled to a $2,500 Rebate in Texas.

    Nano Dimension Ltd. (NASDAQ: NNDM) shares are trading down -28.33% at $4.2 at the time of writing after the company revealed it has entered into definitive agreements with investors for the sale of 25,000,000 of the Company’s American Depositary Shares at a price of $4.00 per ADS pursuant to a registered direct offering. The company’s 52-week range was noted as $0.51 to $6.00. Analysts have a consensus price target of $8.

    Medigus Ltd. (MDGS) tumbled over -0.81% at $2.45 in pre-market trading today. Correction after the news that the company aimed to form a joint venture with EMuze founders to develop and potentially commercialize EV-based micro-mobility vehicles for urban and logistics transportation.

    TransAtlantic Petroleum Ltd. (TAT), an Oil & Gas E&P company, rose about 13.65% at $0.2839 in pre-market trading Friday as the company revealed its Q3 results as offered a business update.

    Hudson Capital Inc. (HUSN) stock moved down -6.69 percent to $2.51 in the pre-market trading after the report of Hudson Capital Inc. and FreightHub, Inc. progressed further with the planned merger.

    Youdao Inc. (DAO) lost over -2.21% at $29.25 in pre-market trading Friday 20 November 2020 after the company reported third-quarter 2020 unaudited financial results.

    Jumia Technologies AG (JMIA) is down more than -2.6% at $23.6 in pre-market hours Friday 20 November 2020 after the reported that the company is finally narrowing losses after the pandemic forced a strategy shift. The stock had jumped over 18.37% to $24.23 in the last trading session.

    Before the trading started on 20 November 2020, CBAK Energy Technology Inc. (CBAT) is down -3.43% to reach $7.33. It has been trading in a 52-week range of $0.36 to $11.40.

    Polar Power Inc. (POLA) stock plunged -3.15% to $4.0 in the pre-market trading. The most recent rating by ROTH Capital, on November 07, 2017, is at a Neutral.

    Westwater Resources Inc. (NASDAQ: WWR) shares are trading up 5.48% at $6.16 at the time of writing after the company revealed Q3 results and offered a business update. The company’s 52-week range was noted as $0.25 to $14.50.

    Oragenics Inc. (OGEN) tumbled over -18.33% at $0.4296 in pre-market trading today after the Company announced that it has commenced a proposed underwritten public offering of common stock of the Company.

    Euroseas Ltd. (ESEA), a Marine Shipping company, dropped about -22.56% at $3.09 in pre-market trading Friday after the firm posted results for the nine-month period and the quarter ended September 30, 2020.

    Fuel Tech Inc. (FTEK) stock moved up 4.5 percent to $1.16 in the pre-market trading as the company revealed Q3 earnings report.

    SPI Energy Co. Ltd. (SPI) lost over -3.1% at $8.45 in pre-market trading Friday 20 November 2020 after the firm closed the sale of a 1.015-megawatt solar project in Maui, Hawaii.

    SG Blocks Inc. (SGBX) is down more than -12.28% at $2.5 in pre-market hours Friday 20 November 2020 after the publications reported that SG Blocks to deliver up to 7,000 COVID-19 PCR tests per shift leveraging Its state-of-the-Art D-TEC module lab solutions. The stock had jumped over 8.78% to $2.85 in the last trading session.

    Before the trading started on 20 November 2020, Senmiao Technology Limited (AIHS) is down 0.0% to reach $1.16, as the company revealed that it has recently launched Xixingtianxia, its own proprietary online ride-sharing platform, to drivers and riders in Chengdu, China, one of its core cities with a population of approximately 16 million. It has been trading in a 52-week range of $0.26 to $2.35.

    Teligent Inc. (TLGT) stock soared 11.65% to $0.6 in the pre-market trading after the company revealed adjournment of a special meeting of stockholders. The most recent rating by Craig Hallum, on August 20, 2020, is at a Hold.

    Waitr Holdings Inc. (NASDAQ: WTRH) shares are trading up 13.45% at $3.88 at the time of writing after the company revealed a Q3 earnings beat. The company’s 52-week range was noted as $0.26 to $5.85. Analysts have a consensus price target of $8.

    Ocean Power Technologies Inc. (OPTT) grew over 7.43% at $2.17 in pre-market trading today after the company revealed receipt of a DeepStar project award to study the deployment and operational requirements of utilizing OPT’s PB3 PowerBuoy to provide remotely controllable zero-carbon power for deepwater subsea oil production applications.

    Artelo Biosciences Inc. (ARTL), a Biotechnology company, rose about 42.51% at $0.8301 in pre-market trading Friday after the company announced receipt of the Clinical Trial Authorization in the UK for the Company’s Cancer Appetite Recovery Study.

    U.S. Energy Corp. (USEG) stock moved up 4.96 percent to $3.6 in the pre-market trading as the company revealed Q3 fiscal and operating results.

    Insignia Systems Inc. (ISIG) lost over -4.4% at $0.87 in pre-market trading Friday 20 November 2020 after the company revealed Q3 and nine months results.

    ADiTx Therapeutics Inc. (ADTX) is down more than -3.43% at $1.97 in pre-market hours Friday 20 November 2020. The stock had jumped over 5.70% to $2.04 in the last trading session. after company secures CLIA certification for AditxtScore Laboratory Operations in Richmond, VA, and plans to launch AditxtScore for COVID-19 as a lab-developed test.

    Before the trading started on 20 November 2020, FuelCell Energy Inc. (FCEL) is down -2.99% to reach $5.2 after the stock rally forced analysts to keep the stock status recommended. It has been trading in a 52-week range of $0.48 to $5.80.

    Lightbridge Corporation (LTBR) stock plunged -5.14% to $2.95 in the pre-market trading as the company revealed Q3 results.

    GSX Techedu Inc. (NYSE: GSX) shares are trading down -12.17% at $62.67 at the time of writing after the firm revealed its third-quarter 2020 results. The company’s 52-week range was noted as $14.21 to $141.78. Analysts have a consensus price target of $38.

    Reed’s Inc. (REED) tumbled over -21.09% at $0.5998 in pre-market trading today. Reed’s Inc after the company revealed outlook for fiscal 2021.

    Hibbett Sports Inc. (HIBB), a Specialty Retail company, rose about 6.81% at $45.0 in pre-market trading Friday after firm earnings results topped estimates.

    Amarin Corporation plc (AMRN) stock moved up 16.74 percent to $5.3 in the pre-market trading as the company shared topline data from the pivotal phase 3 study of VASCEPA® in mainland China.

    Ocugen Inc. (OCGN) gained over 6.48% at $0.34 in pre-market trading Friday 20 November 2020 as the company revealed a business update with Q3 results.

    Vaxart Inc. (VXRT) is up more than 0.51% at $5.94 in pre-market hours Friday 20 November 2020 after the company announced hosting a key opinion leader panel call for investors. The stock had jumped over 3.68% to $5.91 in the last trading session.

    Before the trading started on 20 November 2020, Spectrum Pharmaceuticals Inc. (SPPI) is down -2.12% to reach $4.15. It has been trading in a 52-week range of $1.74 to $10.57.

    Workday Inc. (WDAY) stock plunged -2.9% to $224.11 in the pre-market trading after the company announced fiscal 2021 third-quarter financial results. The most recent rating by Piper Sandler, on October 20, 2020, is at an Overweight.

    NovaBay Pharmaceuticals Inc. (AMEX: NBY) shares are trading up 16.24% at $0.68 at the time of writing as the company published its Q3 earnings report. The company’s 52-week range was noted as $0.24 to $1.94. Analysts have a consensus price target of $1.10.

    Seelos Therapeutics Inc. (SEEL) tumbled over -6.84% at $0.7521 in pre-market trading today after the company received US orphan drug designation for SLS-005 in Amyotrophic Lateral Sclerosis.

    Catalyst Pharmaceuticals Inc. (CPRX), a Biotechnology company, dropped about -2.71% at $3.23 in pre-market trading Friday after analysts changed forecast following an earnings beat.

    360 DigiTech Inc. (QFIN) stock moved up 9.21 percent to $13.52 in the pre-market trading as the company revealed third quarter 2020 Unaudited financial results.

    Lyft Inc. (LYFT) lost over -2.77% at $39.0 in pre-market trading Friday 20 November 2020 following a report that Motional got approval to test fully driverless vehicles in Nevada.

    Corbus Pharmaceuticals Holdings Inc. (CRBP) is down more than -2.48% at $1.18 in pre-market hours Friday 20 November 2020. The stock had jumped over 0.83% to $1.21 in the last trading session.

    Before the trading started on 20 November 2020, BOQI International Medical Inc. (BIMI) is down -2.2% to reach $1.78. It has been trading in a 52-week range of $1.50 to $7.40 following the announcement of its quarterly results.

    FireEye Inc. (FEYE) stock soared 13.97% to $16.23 in pre-market trading. The most recent rating by BMO Capital Markets, on July 29, 2020, is at a Market performance after the firm revealed the acquisition of respond software.

    Akerna Corp. (NASDAQ: KERN) shares are trading down -2.91% at $2.67 at the time of writing after the report that cannabis sales expected to reach approximately $270M over thanksgiving weekend. The company’s 52-week range was noted as $2.17 to $13.50. Analysts have a consensus price target of $18.

     

  • Pre-Market Cues: 45 Stocks Roaring for Change On November 16th

    Pre-Market Cues: 45 Stocks Roaring for Change On November 16th

    CBAK Energy Technology Inc. (CBAT) stock soared 51.22% to $9.3 in pre-market trading.
    Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) shares are trading up 9.74% at $2.14 at the time of writing. The company’s 52-week range was noted as $0.89 to $2.69.
    Electra Meccanica Vehicles Corp. (SOLO) grew over 8.9% at $6.85 in pre-market trading today following analyst’s prediction that electric vehicles will overtake the global automotive sector in the near future.
    CPS Technologies Corporation (CPSH), an Electronic Components company, dropped about -8.72% at $1.57 in pre-market trading Monday.
    HighPoint Resources Corporation (HPR) stock moved up 77.39 percent to $6.67 in the pre-market trading after the news that Bonanza Creek Energy, Inc. BCEI and HighPoint Resources Corporation HPR have agreed on a merger worth $376 million.
    Navidea Biopharmaceuticals Inc. (NAVB) lost over -5.8% at $2.6 in pre-market trading Monday 16 November 2020 after the company announced its financial results for the third quarter and year-to-date 2020.
    Hall of Fame Resort & Entertainment Company (HOFV) is down more than -11.65% at $2.2 in pre-market hours Monday 16 November 2020 as the company and the NFL alumni association offered updates on the success of the inaugural NFL alumni academy. The stock had jumped over 22.06% to $2.49 in the last trading session.
    Before the trading started on 16 November 2020, GreenPower Motor Company Inc. (GP) is up 6.98% to reach $13.48 after the company posted its 2nd quarter financial results for 2021. It has been trading in a 52-week range of $0.82 to $23.45.
    Zomedica Pharmaceuticals Corp. (ZOM) stock plunged -7.07% to $0.088 in the pre-market trading as the plans to initiate commercialization on 30 March 2021 of its TRUFORMATM point-of-care diagnostic platform revealed.
    Polar Power Inc. (NASDAQ: POLA) shares are trading up 7.81% at $3.59 at the time of writing. Company’s 52-week range was noted as $0.95 to $6.56.
    Sino-Global Shipping America Ltd. (SINO) tumbled over -2.92% at $2.66 in pre-market trading today.
    Pinduoduo Inc. (PDD), an Internet Retail company, dropped about -1.78% at $148.59 in pre-market trading Monday as the firm unveils its Q3 results.
    Tellurian Inc. (TELL) stock moved down -4.51 percent to $0.9644 in the pre-market trading as the news appeared that the company is pondering new Asia gas deals After Petronet snub.
    9 Meters Biopharma Inc. (NMTR) lost over -3.58% at $0.8 in pre-market trading Monday 16 November 2020 as the company revealed financial results and business updates.
    Centennial Resource Development Inc. (CDEV) is down more than -2.88% at $0.741 in pre-market hours Monday 16 November 2020 after the company said Sean R. Smith, Chief Executive Officer, is set to attend the Bank of America Securities Global Energy Conference to be held virtually on Thursday. The stock had jumped over 9.14% to $0.76 in the last trading session.
    Before the trading started on 16 November 2020, Genius Brands International Inc. (GNUS) is up 7.38% to reach $1.31, after the company stated that it is set to host a conference call at 10:00 a.m. Eastern Time on Monday, November 16, 2020, to review major initiatives underway and recent developments. The stock has been trading in a 52-week range of $0.05 to $11.73.
    CureVac N.V. (CVAC) stock soared 8.38% to $81.5 in the pre-market trading after the report that the covid-19 vaccine could be a drug industry game-changer. The most recent rating by Jefferies, on September 08, 2020, is a Hold.
    Apple Hospitality REIT Inc. (NYSE: APLE) shares are trading down -2.83% at $12.02 at the time of writing after the company posted 3rd quarter results of operation. The company’s 52-week range was noted as $4.48 to $16.42. Analysts have a consensus price target of $13.
    Transocean Ltd. (RIG) tumbled over -3.7% at $1.04 in pre-market trading today as the company stock soared 53% since the earnings announcement.
    Cinedigm Corp. (CIDM), an Entertainment company, rose about 8.33% at $0.65 in pre-market trading Monday as the company has purchased North American distribution rights to 100 DAYS TO LIVE, a taut psychological thriller set in the world of suicide prevention and mental health.
    Range Resources Corporation (RRC) stock moved down -5.57 percent to $6.78 in pre-market trading as the company recently revealed disappointing earnings.
    UP Fintech Holding Limited (TIGR) gained over 11.9% at $6.02 in pre-market trading Monday 16 November 2020 as the capital market giant revealed that it will announce its Q3 results on November 23, 2020.
    Taubman Centers Inc. (TCO) is up more than 8.11% at $42.68 in pre-market hours Monday 16 November 2020 after the publication report that Simon Property and Taubman have finally agreed on a merger on a well-reduced price of $43.00 per share in cash. The stock had jumped over 5.53% to $39.48 in the last trading session.
    Before the trading started on 16 November 2020, Banco Bilbao Vizcaya Argentaria S.A. (BBVA) is up 15.24% to reach $4.31 after the announcement that PNC Financial Services Group Inc (NYSE: PNC) is set to take over Banco Bilbao Vizcaya Argentaria (BBVA) U.S. business in an $11 billion all-cash deal. The stock has been trading in a 52-week range of $2.49 to $5.80.
    Kandi Technologies Group Inc. (KNDI) stock soared 7.62% to $7.77 in the pre-market trading as the Company announced that It completed a registered direct offering of 9,404,392 shares of its securities at a sales price of $6.38 per share, raising about $60,000,000 in net gross proceeds to the Firm before deducting the selling agent’s fees and other expected offering expenditures incurred by the Company.
    Textainer Group Holdings Limited (NYSE: TGH) shares are trading down -5.5% at $15.65 at the time of writing after the company posted its third-quarter results. The company’s 52-week range was noted as $5.50 to $17.33. Analysts have a consensus price target of $18.
    Gulfport Energy Corporation (GPOR) tumbled over -45.61% at $0.13 in pre-market trading today after the company filed for bankruptcy.
    Akerman Corp. (KERN), a Health Information Services company, dropped about -3.46% at $2.79 in pre-market trading Monday after the company posted its earnings results.
    United States Antimony Corporation (UAMY) stock moved up 4.17 percent to $0.375 in the pre-market trading.
    ADiTx Therapeutics Inc. (ADTX) lost over -2.03% at $1.93 in pre-market trading Monday 16 November 2020 as the company offered the latest business updated as well as its fiscal quarterly report.
    Arbutus Biopharma Corporation (ABUS) is up more than 10.19% at $4.0 in pre-market hours Monday 16 November 2020 after the firm revealed presentation of phase 1a/1b clinical trial results for AB-729 in chronic hepatitis B subjects at the liver meeting digital experience, the American Association for the study of Liver Diseases meeting. The stock had jumped over 2.25% to $3.63 in the last trading session.
    Before the trading started on 16 November 2020, Ideanomics Inc. (IDEX) is up 31.31% to reach $1.3 after the company revealed the final agreement to take over Timios holding corps. It has been trading in a 52-week range of $0.28 to $3.98.
    Pacific Ethanol Inc. (PEIX) stock soared 4.71% to $6.0 in the pre-market trading as the company announced Q3 results. The most recent rating by BWS Financial, on September 22, 2020, is a Buy.
    CEL-SCI Corporation (AMEX: CVM) shares are trading up 10.5% at $14.0 at the time of writing. The company’s 52-week range was noted as $6.35 to $18.00. Analysts have a consensus price target of $18.
    AMC Entertainment Holdings Inc. (AMC) grew over 8.42% at $3.22 in pre-market trading today following news that Cinemark joins AMC in pursuing a shortened movie window.
    Sogou Inc. (SOGO), an Internet Content & Information company, dropped about -3.14% at $8.64 in pre-market trading Monday as the company unveiled its Q3, 2020 results.
    ObsEva SA (OBSV) stock moved up 18.84 percent to $2.46 in the pre-market trading as the company announced the positive topline results of PROLONG, the Phase 2a proof-of-concept, randomized, double-blind, placebo-controlled trial of laropiprant in preterm labor.
    Denison Mines Corp. (DNN) lost over -9.3% at $0.32 in pre-market trading Monday 16 November 2020 after the company announced the establishment of the At-The-Market Program.
    Pyxis Tankers Inc. (PXS) is down more than -25.74% at $0.8763 in pre-market hours Monday 16 November 2020 as the company announced results for its 3rd quarter and year to date. The stock had dropped over 0.00% to $1.18 in the last trading session.
    Before the trading started on 16 November 2020, Qutoutiao Inc. (QTT) is down -2.13% to reach $2.3. It has been trading in a 52-week range of $2.12 to $6.55.
    Uxin Limited (UXIN) stock plunged -3.85% to $1.0 in the pre-market trading after the news that the company’s Net Promoter Score (NPS) increases to 30 during the quarter ended September 30, 2020. The most recent rating by JP Morgan, on October 23, 2019, is at a Neutral.
    VistaGen Therapeutics Inc. (NASDAQ: VTGN) shares are trading down -2.13% at $0.6851 at the time of writing. The company’s 52-week range was noted as $0.29 to $1.15. Analysts have a consensus price target of $6.
    Sypris Solutions Inc. (SYPR), an Auto Parts company, dropped about -3.6% at $1.34 in pre-market trading Monday after the company announced its 3rd quarter earnings results.
    Alterity Therapeutics Limited (ATHE) stock moved up 169.57 percent to $3.1 in the pre-market trading.